Spero Therapeutics's market cap is currently $45.62M. The company's EPS TTM is $0.079; its P/E ratio is 10.53; Spero Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 96.73M	$ 48.58M	$ 18.26M	$ 9.33M	$ 4.74M
Gross Profit	$ 96.37M	$ 47.03M	$ 17.14M	$ -57.67M	$ -61.03M
Operating Income	$ 21.48M	$ -42.20M	$ -87.97M	$ -79.11M	$ -63.22M
EBITDA	$ 25.77M	$ -42.26M	$ -87.17M	$ -76.93M	$ -62.47M
Net Income	$ 22.81M	$ -48.03M	$ -91.30M	$ -77.52M	$ -60.17M
Balance Sheet
Cash & Short-Term Investments	$ 76.33M	$ 109.11M	$ 146.40M	$ 126.91M	$ 82.05M
Total Assets	$ 182.39M	$ 124.80M	$ 171.07M	$ 153.45M	$ 106.10M
Total Debt	$ 5.54M	$ 6.65M	$ 7.33M	$ 7.84M	$ 5.54M
Net Debt	$ -70.79M	$ -102.46M	$ -105.25M	$ -77.37M	$ -24.18M
Total Liabilities	$ 75.50M	$ 48.87M	$ 82.78M	$ 21.41M	$ 31.53M
Stockholders' Equity	$ 106.89M	$ 75.93M	$ 88.29M	$ 132.04M	$ 74.57M
Cash Flow
Free Cash Flow	$ -32.99M	$ -7.73M	$ -64.31M	$ -86.03M	$ -50.33M
Operating Cash Flow	$ -32.99M	$ -7.73M	$ -64.35M	$ -85.87M	$ -50.02M
Investing Cash Flow	$ 0.00	$ 33.81M	$ 7.67M	$ 10.47M	$ 29.53M
Financing Cash Flow	$ 221.00K	$ -29.55M	$ 84.05M	$ 130.88M	$ 16.14M

Currency in USD

Spero Therapeutics Earnings and Revenue History

Income Statement >

Spero Therapeutics Debt to Assets

Balance Sheet >

Spero Therapeutics Cash Flow

Cash Flow >

Spero Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing